Percutaneous methods of left atrial appendage exclusion: an alternative to the internist

References

• Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, etal. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285: 2370–75.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, etal. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114: 119–25.
   PubMed Web of Science ®Google Scholar
• Poli D, Antonucci E, Grifoni E, Abbate R, Gensini GF, Prisco D. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol. 2009; 54: 999–1002.
   PubMed Web of Science ®Google Scholar
• Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation. 1998; 97: 1231–3.
   PubMed Web of Science ®Google Scholar
• Gottlieb LK, Salem-Schatz S. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?. Arch Intern Med. 1994; 154(17): 1945–53.
   PubMedGoogle Scholar
• Cruz-Gonzalez I, Yan BP, Lam Y. Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv. 2010; 75: 806–13.
   PubMed Web of Science ®Google Scholar
• Morelli R, Khodjaev S. Percutaneous left atrial appendage closure ligation and exclusion as an alternative stroke prevention in patients with nonvalvular atrial fibrillation. EP Lab Dig. 2012; 20–2.
   Google Scholar
• Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996; 61(2): 755–9.
   PubMed Web of Science ®Google Scholar
• ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol. 1998; 32(5): 1486–588.
   PubMed Web of Science ®Google Scholar
• Katz ES, Tsiamtsiouris T, Applebaum RM, Schwartzbard A, Tunick PA, Kronzon I. Surgical left atrial appendage ligation is frequently incomplete: a tranesophageal echocardiographic study. J Am Coll Cardiol. 2000; 36: 468–71.
   PubMed Web of Science ®Google Scholar
• Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, etal. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002; 105: 1887–9.
   PubMed Web of Science ®Google Scholar
• Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, etal. Percutaneous Left Atrial Appendage Transcatheter Occlusion (PLAATO System) to Prevent Stroke in High-Risk Patients With Non-Rheumatic Atrial Fibrillation. J Am Coll Cardiol. 2005; 46(1): 9–14.
   PubMed Web of Science ®Google Scholar
• Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, etal. Percutaneous Left Atrial Appendage Occlusion for patients in atrial fibrillation suboptimal for warfarin therapy. J Am Coll Cardiol. 2009; 2: 594–600.
   Google Scholar
• El-Chami MF, Grow P, Eilen D, Lerakis S, Block PC. Clinical outcomes three years after PLAATO implantation. Catheter Cardiovasc Interv. 2007; 69: 704–7.
   PubMed Web of Science ®Google Scholar
• Kao J, Shivaraju A. Preventing left atrial appendage emboli. Transcatheter LAA occluders are in clinical trials seeking FDA clearance as a replacement for warfarin therapy. Diagnostic and Interventional Cardiology. Web. 7, Sept 2010.
   Google Scholar
• Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, etal. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003; 60: 417–22.
   PubMed Web of Science ®Google Scholar
• Nietlispach F, Gloekler S, Krause R, Shakir S, Schmid M, Khattab AA, etal. Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheter Cardiovasc Interv. 2013; 82: 283–9.
   PubMed Web of Science ®Google Scholar
• Lam L, Yip GW, Yu CM, Chan WW, Cheng BC, Yan BP, etal. Left atrial appendage closure with Amplatzer Cardiac Plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv. 2012; 79: 794–800.
   Web of Science ®Google Scholar
• Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, etal. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007; 49: 1490–5.
   PubMed Web of Science ®Google Scholar
• Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, etal. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial. Lancet. 2009; 374: 534–42.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011; 123: 417–24.
   PubMed Web of Science ®Google Scholar
• Reddy VY, Neuzil P, Miller MA, Schuler G, Mobius-Winkler SS, Wiebe J, etal. LB02-2- First Formal Analysis of The ‘ASA Plavix Registry’ (ASAP): watchman left atrial appendage closure in atrial fibrillation patients with contraindication to oral anticoagulation. Breaking abstract session presented at Heart Rhythm Scientific Sessions. 2012. Friday May 11.
   Google Scholar
• PREVAIL Yanked from ACC Program; Watchman device meets safety end point. Medscape. 2013. Mar 9.
   Google Scholar
• Bartus K, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, etal. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm. 2011; 8: 188–93.
   PubMed Web of Science ®Google Scholar
• Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, Sadowski J, etal. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation. J Am Coll Cardiol. 2013; 62(2): 108–18.
   PubMed Web of Science ®Google Scholar
• Chiam PT, Ruiz CE. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation. J Invasisve Cardiol. 2008; 20(4): E109–13.
   Google Scholar
• Nicholson W. Left Atrial Appendage Occlusion with the Amplazter Cardiac Plug. EP Lab Digest. 2010; 10(11): 22–23.
   Google Scholar
• Boston Scientific. WATCHMAN Left Atrial Appendage Closure Device. Available from: www.bostonscientific.com/watchman-eu/.
   Google Scholar
• SentreHeart. Lariat Suture Delivery Device. Available from: www.sentreheart.com/us/products/lariat.
   Google Scholar